Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe two screenshots show only minor UI/layout updates with no changes to core study details (inclusion criteria, outcomes, enrollment, status, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedAdded a government operating status notice and updated version to v3.2.0; removed a previous specific disease term and downgraded to v3.1.0. The update emphasizes current operating status and versioning over the deleted term.SummaryDifference5%

- Check49 days agoChange Detected- The page now shows Revision: v3.1.0 (new). - The previous Revision: v3.0.2 was removed (updated version).SummaryDifference0.1%

- Check63 days agoChange DetectedPage revised from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.3%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.3%

- Check78 days agoChange DetectedThe web page has been updated to include new facility and publication information, specifically related to various types of leukemia and lymphoma, while removing some previous location and disease terms.SummaryDifference10%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.